IC 31 seasonal influenza vaccine (CSL/Valneva)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIC 31 seasonal influenza vaccine (CSL/Valneva)
Drug Alias NameIC31 Flu vaccine (CSL/Valneva)Seasonal trivalent influenza vaccine (Agrippal + IC31)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgValneva
China Registration ClassN/A

Develop Information

Active CompaniesValnevaCsl LtdNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A